Nephro-protective role of morin against experimentally induced diabetic nephropathy

Digest Journal of Nanomaterials and Biostructures

Volumn 8, Issue , 2013, Pages 395-401

  Aleisa, Abdulaziz M ^a   Al Rejaie, Salim S ^a   Abuohashish, Hatem M ^a   Ahmed, Mohammed M ^b   Parmar, Mihir Y ^b  

^a Department of Pharmacology and Toxicology ^*  (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Morin; Nephropathy; Streptozotocin

Indexed keywords

EID: 84874328780     PISSN: None     EISSN: 18423582     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. J.E. Shaw, R.A. Sicree, P.Z. Zimmet, Diabetes. Res. Clin. Pract. 87, 4 (2010).
2. J. Asbun, F.J. Villarreal, J. Am. Coll. Cardiol. 47, 693 (2006).
3. T.S. Oluleye, Afr. J. Med. Med. Sci. 39, 199 (2010).
4. V. Poitout, R.P. Robertson, Endocrinology 143, 339 (2002).
5. G. Sadi, N. Eryilmaz, E. Tutuncuoglu, S. Cingir, T. Guray, Diabetes. Metab. Res. Rev. 28, 228 (2012).
6. A. Ceriello, N. Bortolotti, E. Falleti, C. Taboga, L. Tonutti, A. Crescentini, E. Motz, S. Lizzio, A. Russo, E. Bartoli, Diabetes. Care. 20, 194 (1997).
7. R.J. Shelton, P. Velavan, N.P. Nikitin, A.P. Coletta, A.L. Clark, A.S. Rigby, N. Freemantle, J.G. Cleland, Eur. J. Heart. Fail. 7, 127 (2005).
8. R. Nandhakumar, K. Salini, S. Niranjali Devaraj, Mol. Cell. Biochem. 364, 79 (2012).
9. C. Wang, Y. Pan, Q.Y. Zhang, F.M. Wang, L.D. Kong, PLoS One 7, e38285 (2012).
10. M.G. Saklayen, J. Yap, V. Vallyathan, J. Investig. Med. 58, 28 (2010).
11. M. Kanter, S. Sen, S. Donmez, C. Aktas, S. Ustundag, M. Erboga, Ren. Fail. 32, 498 (2010).
12. A. Bregman, Laboratory Investigation and Cell Biology, John Wiley and Sons New York, (1983).
13. G.R. Schacterle, R.L. Pollack, Anal. Biochem. 51, 654 (1973).
14. J. Sedlak, R.H. Lindsay, Anal. Biochem. 25, 192 (1968).
15. Y. Kono, Arch. Biochem. Biophys. 186, 189 (1978).
16. H. Aebi, Catalase in: Bergmeyer, (Ed.), Methods in enzymatic analysis, New York, (1974).
17. R. Kapoor, S. Srivastava, P. Kakkar, Environ. Toxicol. Pharmacol. 27, 62 (2009).
18. S.O. Adewole, S.K. Ojo, T.K. Adenowo, A.A. Salako, T. Naicker, J.A. Ojewole, Folia. Morphol. (Warsz) 71, 1 (2012).
19. S.M. Nurulain, G. Petroianu, M. Shafiullah, H. Kalasz, M. Oz, T. Saeed, A. Adem, E. Adeghate, J. Appl. Toxicol. (2012).
20. I.G. Brodsky, J. Nutr. 128, 337S (1998).
21. C. Keembiyehetty, R. Augustin, M.O. Carayannopoulos, S. Steer, A. Manolescu, C.I. Cheeseman, K.H. Moley, Mol. Endocrinol. 20, 686 (2006).
22. Q. Cheng, L.M. Aleksunes, J.E. Manautou, N.J. Cherrington, G.L. Scheffer, H. Yamasaki, A.L. Slitt, Mol. Pharm. 5, 77 (2008).
23. P. Hovind, P. Rossing, R.J. Johnson, H.H. Parving, J. Ren. Nutr. 21, 124 (2011).
24. P. Hovind, P. Rossing, L. Tarnow, R.J. Johnson, H.H. Parving, Diabetes 58, 1668 (2009).
25. S.S. Iyer, W.P. Pulskens, J.J. Sadler, L.M. Butter, G.J. Teske, T.K. Ulland, S.C. Eisenbarth, S. Florquin, R.A. Flavell, J.C. Leemans, F.S. Sutterwala, Proc. Natl. Acad. Sci. 106, 20388 (2009).
26. V. Jakus, Bratisl. Lek. Listy. 101, 541 (2000).
27. S.F. Picton, P.R. Flatt, N.H. McClenaghan, Int. J. Exp. Diabetes. Res. 2, 19 (2001).
28. P. Shokeen, P. Anand, Y.K. Murali, V. Tandon, Food. Chem. Toxicol. 46, 3458 (2008).
29. M.A. Ajabnoor, J. Ethnopharmacol. 28, 215 (1990).
30. J.D. McGarry, Diabetes. 51, 7 (2002).
31. P. Schmezer, C. Eckert, U.M. Liegibel, Mutat. Res. 307, 495 (1994).
32. R. Verma, D. Chakraborty, Acta. Pol. Pharm. 65, 3 (2008).
33. A. Imaeda, T. Kaneko, T. Aoki, Y. Kondo, H. Nagase, Food. Chem. Toxicol. 40, 979 (2002).
34. P. Prahalathan, S. Kumar, B. Raja, Metabolism. 61, 1087 (2012).
35. A. Merwid-Lad, M. Trocha, E. Chlebda, T. Sozanski, J. Magdalan, D. Ksiadzyna, M. Kopacz, A. Kuzniar, D. Nowak, M. Piesniewska, L. Fereniec-Golebiewska, J. Kwiatkowska, A. Szelag, Hum. Exp. Toxicol. 31, 812 (2012).
36. R. Kapoor, P. Kakkar, PLoS. One. 7, e41663 (2012).
37. L.D. Kok, Y.P. Wong, T.W. Wu, H.C. Chan, T.T. Kwok, K.P. Fung, Life. Sci. 67, 91 (2000).